CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) [Phase 1]
Summary
Phase 1 multiple ascending dose study of MHS552 in adults with systemic lupus erythematosus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Lupus Erythematosus, Systemic | Phase 1 | Status: TERMINATED